Literature DB >> 22077060

MicroRNA regulation of STAT4 protein expression: rapid and sensitive modulation of IL-12 signaling in human natural killer cells.

Yong Huang1, YingFeng Lei, Hai Zhang, LiChao Hou, Mingjie Zhang, Andrew I Dayton.   

Abstract

IL-12 exerts several regulatory effects on natural killer (NK) cells by activating IL-12 signaling. IL-12 signaling is tightly auto-regulated to control its onset and termination, with prolonged IL-12 treatment resulting in IL-12 hyporesponsiveness. However, the mechanisms underlying IL-12 auto-regulation are still unclear. In this study we report that prolonged IL-12 treatment significantly up-regulates microRNAs (miRNAs), including miR-132, -212, and -200a in primary human NK cells. This up-regulation correlates temporally with gradually decreasing STAT4 levels and decreasing IFN-γ expression, after an initial increase within the first 16 hours of IL-12 treatment. The IL-12 hyporesponsiveness is dependent on IL-12 concentration, and associated up-regulation of miR-132, -212, and -200a. Furthermore, IL-12-hyporesponsive cells regain responsiveness of IFN-γ production 24 hours after IL-12 removal, which correlates with decreases in miR-132, -212, and -200a levels. Overexpression of miR-132, -212, and -200a by transfection into NK cells mimics IL-12 priming, inducing IL-12 hyporesponsiveness, whereas transfection of miR-132, -212, and -200a inhibitors largely abolishes IL-12 induction of IL-12 hyporesponsiveness. These data suggest that miR-132, -212, and -200a up-regulation during prolonged IL-12 treatment, negatively regulates the IL-12 signaling pathway by reducing STAT4 expression in primary human NK cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22077060     DOI: 10.1182/blood-2011-05-356162

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

1.  microRNA cluster 106a~363 is involved in T helper 17 cell differentiation.

Authors:  Marc Kästle; Sabine Bartel; Kerstin Geillinger-Kästle; Martin Irmler; Johannes Beckers; Bernhard Ryffel; Oliver Eickelberg; Susanne Krauss-Etschmann
Journal:  Immunology       Date:  2017-07-28       Impact factor: 7.397

Review 2.  microRNA management of NK-cell developmental and functional programs.

Authors:  Jeffrey W Leong; Ryan P Sullivan; Todd A Fehniger
Journal:  Eur J Immunol       Date:  2014-09-16       Impact factor: 5.532

Review 3.  Exploring microRNAs in diabetic chronic cutaneous ulcers: Regulatory mechanisms and therapeutic potential.

Authors:  Xuqiang Nie; Jiufeng Zhao; Hua Ling; Youcai Deng; Xiaohui Li; Yuqi He
Journal:  Br J Pharmacol       Date:  2020-08-13       Impact factor: 8.739

4.  Correlation of MicroRNA 132 Up-regulation with an Unfavorable Clinical Outcome in Patients with Primary Glioblastoma Multiforme Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide Chemotherapy.

Authors:  Nicole R Parker; Nelson Correia; Brendan Crossley; Michael E Buckland; Viive M Howell; Helen R Wheeler
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

5.  Swainsonine promotes apoptosis in human oesophageal squamous cell carcinoma cells in vitro and in vivo through activation of mitochondrial pathway.

Authors:  Zhaocal Li; Yong Huang; Feng Dong; Wei Li; Li Ding; Gaoshui Yu; Dan Xu; Yuanyuan Yang; Xingang Xu; Dewen Tong
Journal:  J Biosci       Date:  2012-12       Impact factor: 1.826

Review 6.  Mini but mighty: microRNAs in the pathobiology of periodontal disease.

Authors:  Moritz Kebschull; Panos N Papapanou
Journal:  Periodontol 2000       Date:  2015-10       Impact factor: 7.589

Review 7.  Interferon receptor signaling in malignancy: a network of cellular pathways defining biological outcomes.

Authors:  Eleanor N Fish; Leonidas C Platanias
Journal:  Mol Cancer Res       Date:  2014-09-12       Impact factor: 5.852

Review 8.  Transcriptional and post-transcriptional regulation of NK cell development and function.

Authors:  Jeffrey W Leong; Julia A Wagner; Aaron R Ireland; Todd A Fehniger
Journal:  Clin Immunol       Date:  2016-03-03       Impact factor: 3.969

9.  Constitutive IFNα/β signaling maintains expression of signaling intermediaries for efficient cytokine responses.

Authors:  Nicole L Messina; Christopher J P Clarke; Ricky W Johnstone
Journal:  JAKSTAT       Date:  2016-05-18

10.  MicroRNA regulation of natural killer cells.

Authors:  Ryan P Sullivan; Jeffrey W Leong; Todd A Fehniger
Journal:  Front Immunol       Date:  2013-02-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.